Sharon E. Underberg - Feb 14, 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
EVP, GC & Corp. Secretary
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg
Stock symbol
IDXX
Transactions as of
Feb 14, 2022
Transactions value $
-$127,899
Form type
4
Date filed
2/16/2022, 06:29 PM
Next filing
Feb 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +483 +25.17% $0.00 2.4K Feb 14, 2022 Direct F1
transaction IDXX Common Stock Options Exercise $0 +217 +9.03% $0.00 2.62K Feb 14, 2022 Direct
transaction IDXX Common Stock Options Exercise $0 +138 +5.27% $0.00 2.76K Feb 14, 2022 Direct
transaction IDXX Common Stock Tax liability -$128K -253 -9.18% $505.53 2.5K Feb 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award +5.92K 5.92K Feb 14, 2022 Common Stock 5.92K $505.53 Direct F2, F8
transaction IDXX Incentive Stock Option (right-to-buy) Award +197 197 Feb 14, 2022 Common Stock 197 $505.53 Direct F3, F8
transaction IDXX Restricted Stock Unit Award +692 +26.12% 3.34K Feb 14, 2022 Common Stock 692 Direct F4, F8
transaction IDXX Restricted Stock Unit Options Exercise -483 -14.46% 2.86K Feb 14, 2022 Common Stock 483 Direct F5, F8
transaction IDXX Restricted Stock Unit Options Exercise -217 -7.59% 2.64K Feb 14, 2022 Common Stock 217 Direct F6, F8
transaction IDXX Restricted Stock Unit Options Exercise -138 -5.23% 2.5K Feb 14, 2022 Common Stock 138 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 40.9949 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021.
F2 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023.
F3 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.
F4 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
F7 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F8 Not applicable.